To characterize inhibitor efficacy, we also investigated 20 inhibitors using different ZDHHC17-positive patient-derived glioblastoma sphere samples (Figure 5A), finding that 12 exhibited therapeutic effects. Here, ZDHHC17 is linked to glioblastoma.